Overview
Laura Kaiser practices practicing medicine in Koeln, Germany.
Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, and Neuroendocrine Tumor.
She is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Laura Kaiser
Is Laura Kaiser a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Laura Kaiser is classified as an Experienced expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Laura Kaiser participate in research or clinical trials?
Yes. Laura Kaiser has published 14 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Laura Kaiser's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerMs. Kaiser isExperienced. Learn about Lung Cancer.
- Neuroendocrine TumorMs. Kaiser isExperienced. Learn about Neuroendocrine Tumor.
- Small Cell Lung Cancer (SCLC)Ms. Kaiser isExperienced. Learn about Small Cell Lung Cancer (SCLC).